These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2557225)

  • 1. Paradoxical response of plasma beta-endorphin to combined administration of TRH and GnRH in adrenal disorders.
    Knappe G; Gerl H; Rückert RI; Rückert Y; Rohde W; Stahl F
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):157-62. PubMed ID: 2557225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
    Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian pattern of serum androgens in women with Cushing's syndrome.
    Kreze A; Mikulecky M; Putz Z; Moravcik M
    Acta Med Hung; 1992-1993; 49(3-4):171-8. PubMed ID: 1345454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF.
    Schulte HM; Allolio B; Günther RW; Benker G; Windeck R; Winkelmann W; Reinwein D
    Horm Metab Res Suppl; 1987; 16():66-7. PubMed ID: 2832295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACTH, beta-endorphin and lipotropins: physiopathological studies in man (author's transl)].
    Kuhn JM; Luton JP; Bricaire H
    Ann Med Interne (Paris); 1982; 133(3):148-51. PubMed ID: 6285791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma testosterone determination in some cases of hirsutism and virilism of adrenal origin.
    Sciarra F
    Folia Endocrinol; 1966 Jun; 19(3):241-8. PubMed ID: 4290066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
    Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
    Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease.
    Giustina A; Bossoni S; Buffoli MG; Ferrari C; Pozzi A; Scalvini T; Schettino M
    Horm Metab Res; 1992 May; 24(5):248-50. PubMed ID: 1398468
    [No Abstract]   [Full Text] [Related]  

  • 13. Circadian rhythm of beta-endorphin in the plasma of clinically healthy subjects and in patients with adrenocortical disorders.
    Nicolau GY; Haus E; Lakatua D; Popa M; Marinescu I; Ionescu B; Bogdan C; Popescu M; Sackett-Lundeen L; Robu E
    Endocrinologie; 1986; 24(3):185-95. PubMed ID: 2946069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of beta-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal-axis of normal human subjects.
    Schulte HM; Allolio B
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):526-30. PubMed ID: 2175140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
    Zacharieva S; Matrosov P; Stoeva I; Kirilov G
    Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma dehydroepiandrosterone sulfate in normal and pathological conditions.
    Yamaji T; Ibayashi H
    J Clin Endocrinol Metab; 1969 Feb; 29(2):273-8. PubMed ID: 4303580
    [No Abstract]   [Full Text] [Related]  

  • 17. Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.
    Demura R; Demura H; Nunokawa T; Baba H; Miura K
    J Clin Endocrinol Metab; 1972 May; 34(5):852-9. PubMed ID: 4335044
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone, chlorpromazine and L-dopa or bromocriptin tests in Cushing's syndrome due to adrenal hyperplasia and adrenal adenoma.
    Chen FW; Chang CC; Huang TS; Chang TC
    Taiwan Yi Xue Hui Za Zhi; 1981 Jan; 80(1):7-18. PubMed ID: 6795309
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma cortisol response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone in Cushing's disease.
    Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1979 May; 48(5):874-6. PubMed ID: 107184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation between urinary 17-hydroxycorticosteroid (17-OHCS) excretion and thyrotropin-releasing hormone (TRH)-induced thyrotropin (TSH) response in disorders of adrenocorticotropic hormone (ACTH) and adrenal secretion.
    Mashito T; Takada I; Kenbo T; Watanabe A
    Endocrinol Jpn; 1981 Apr; 28(2):145-9. PubMed ID: 6273137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.